Literature DB >> 1320499

The neuropathology of hereditary spastic paraparesis.

R P Bruyn1.   

Abstract

Hereditary spastic paraparesis or Strümpell's disease is a genetically determined neurodegenerative disorder in which the signs and symptoms are predominant in the legs. Inheritance is usually autosomal dominant and in a minority recessive. Neuropathological study reveals a degeneration of the corticospinal tract decreasing from lower lumbar to cervical level and of posterior columns increasing from lumbar to upper cervical level as well as degeneration of the spinocerebellar tracts in approximately 50%. The nature of this nucleo-distal central axonopathy and clinicopathological discrepancy for posterior columns, as well as the limits of the pathological process are poorly understood.

Entities:  

Mesh:

Year:  1992        PMID: 1320499     DOI: 10.1016/0303-8467(92)90010-z

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  14 in total

Review 1.  Hereditary spastic paraparesis: a review of new developments.

Authors:  C McDermott; K White; K Bushby; P Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

2.  Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1.

Authors:  Orly Lazarov; Gerardo A Morfini; Gustavo Pigino; Archana Gadadhar; Xiangjun Chen; John Robinson; Hanson Ho; Scott T Brady; Sangram S Sisodia
Journal:  J Neurosci       Date:  2007-06-27       Impact factor: 6.167

3.  Autosomal dominant pure spastic paraplegia: a clinical, paraclinical, and genetic study.

Authors:  J E Nielsen; K Krabbe; P Jennum; P Koefoed; L N Jensen; K Fenger; H Eiberg; L Hasholt; L Werdelin; S A Sørensen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

4.  VPS53 gene is associated with a new phenotype of complicated hereditary spastic paraparesis.

Authors:  Moran Hausman-Kedem; Shay Ben-Shachar; Shay Menascu; Karen Geva; Liora Sagie; Aviva Fattal-Valevski
Journal:  Neurogenetics       Date:  2019-08-16       Impact factor: 2.660

5.  Dalfampridine in hereditary spastic paraplegia: a prospective, open study.

Authors:  Matthieu Béreau; Mathieu Anheim; Jean-Baptiste Chanson; Grégory Tio; Andoni Echaniz-Laguna; Christel Depienne; Nicolas Collongues; Jérôme de Sèze
Journal:  J Neurol       Date:  2015-03-26       Impact factor: 4.849

6.  Iron-sensitive MR imaging of the primary motor cortex to differentiate hereditary spastic paraplegia from other motor neuron diseases.

Authors:  Mirco Cosottini; Graziella Donatelli; Ivana Ricca; Francesca Bianchi; Daniela Frosini; Vincenzo Montano; Gianmichele Migaleddu; Eleonora Del Prete; Alessandra Tessa; Paolo Cecchi; Claudio D'Amelio; Gabriele Siciliano; Michelangelo Mancuso; Filippo Maria Santorelli
Journal:  Eur Radiol       Date:  2022-05-20       Impact factor: 7.034

7.  Clinical Spectrum of Hereditary Spastic Paraplegia in Children: A study of 74 cases.

Authors:  Roshan Koul; Fathiya M Al-Murshedi; Faisal M Al-Azri; Ranjit Mani; Rana A Abdelrahim; Vivek Koul; Amna M Alfutaisi
Journal:  Sultan Qaboos Univ Med J       Date:  2013-06-25

8.  Urodynamic evaluation of patients with autosomal dominant pure spastic paraplegia linked to chromosome 2p21-p24.

Authors:  L N Jensen; T Gerstenberg; E B Kallestrup; P Koefoed; J Nordling; J E Nielsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

9.  MR imaging findings in autosomal recessive hereditary spastic paraplegia.

Authors:  R Hourani; T El-Hajj; W H Barada; M Hourani; B I Yamout
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-04       Impact factor: 3.825

10.  Electrophysiological characterisation of motor and sensory tracts in patients with hereditary spastic paraplegia (HSP).

Authors:  Kathrin N Karle; Rebecca Schüle; Stephan Klebe; Susanne Otto; Christian Frischholz; Inga Liepelt-Scarfone; Ludger Schöls
Journal:  Orphanet J Rare Dis       Date:  2013-10-09       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.